Title:The Inverse Relationship Between Cancer and Alzheimer's Disease: A Possible Mechanism
Volume: 14
Issue: 8
Author(s): Daniel W. Nixon*
Affiliation:
- Adjunct Clinical Professor of Medicine, Morehouse School of Medicine, 1611 Atlantic Ave, Sullivan's Island, SC 29482,United States
Keywords:
Cancer, Alzheimer's disease, leptin, adiponectin, adipokines, p53, Wnt.
Abstract: Background: Cancer and Alzheimer's disease (AD) are both associated with aging, but do not often occur
together. Obesity is a shared risk factor for both diseases and may be involved in this curious clinical observation. Fat
cells produce many active substances, including leptin and adiponectin; leptin has cancer stimulating and AD inhibiting
properties, while adiponectin can inhibit cancer but stimulate AD.
Objective: To describe the opposing effects of leptin and adiponectin on cancer and AD, to outline signaling pathways
involved in these effects and to suggest new research on effective control strategies for both diseases.
Methods: A review was conducted to document the inverse cancer/AD relationship and the role of excess body fat as
a common risk factor. Previous studies have suggested the involvement of p53, Wnt and other cell signaling pathways
in this inverse relationship. The opposing effects of leptin and adiponectin on these signaling pathways in cancer
and AD were evaluated.
Results: The inverse cancer/AD relationship is well documented, as is the role of excess body fat, especially central
obesity, in increasing risk for both diseases. Leptin and adiponectin have opposing effects in cancer and AD mediated
by signaling factors that influence apoptosis, angiogenesis, and other cell growth controls. Wnt and p53 are prominent
among these signaling factors.
Conclusion: Opposing effects of leptin and adiponectin, mediated by specific cell signaling pathways, are involved in
the inverse cancer/Ad relationship. Future research aimed at modifying the leptin/adiponectin ratio may lead to important
treatment and control approaches in both cancer and AD.
